INTERNATIONAL PATENT: SINGLOMICS BEIJING DANXU BIOPHARMACEUTICALS CO., LTD., 北京丹序生物制药有限公司 FILES APPLICATION FOR "ANTI-TRIGGERING RECEPTOR-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF"

GENEVA, Oct. 3 -- SINGLOMICS BEIJING DANXU BIOPHARMACEUTICALS CO., LTD. (D302, Innovation Building, No. 29 Life Science Park RoadChangping District, Beijing 102206), 北京丹序生物制药有限公司 (中国北京市昌平区生命园路29号创新大厦D302) filed a patent application (PCT/CN2025/083377) for "ANTI-TRIGGERING RECEPTOR-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF" on Mar 19, 2025. With publication no. WO/2025/201129, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the Internationa...